Knight Therapeutics (GUD) News Today → Urgent Nvidia Warning (From Altimetry) (Ad) Free GUD Stock Alerts C$5.88 +0.06 (+1.03%) (As of 10:10 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineKnight Therapeutics (GUD) to Release Quarterly Earnings on Thursdaymarketbeat.com - May 3 at 9:15 AMKnight Therapeutics (TSE:GUD) PT Raised to C$5.40 at Stifel Nicolausamericanbankingnews.com - May 3 at 2:38 AMKnight Therapeutics (TSE:GUD) PT Raised to C$5.40marketbeat.com - May 1 at 2:08 PMKnight Therapeutics Inc (GUD)investing.com - April 21 at 8:30 AMTSX Healthcare in April 2024: The Best Stocks to Buy Right Nowmsn.com - April 16 at 5:45 PMKnight Therapeutics Inc. (TSE:GUD) Insider Sime Armoyan Sells 10,900 Sharesinsidertrades.com - April 16 at 4:40 AMSime Armoyan Sells 10,900 Shares of Knight Therapeutics Inc. (TSE:GUD) Stockmarketbeat.com - April 15 at 10:58 AMKnight Therapeutics (TSE:GUD) Reaches New 1-Year High at $5.80marketbeat.com - April 10 at 2:51 PMKnight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conferencefinance.yahoo.com - April 9 at 8:17 AMKnight Therapeutics Inc. (TSE:GUD) Insider Buys C$32,550.00 in Stockinsidertrades.com - April 9 at 4:48 AMInsider Buying: Knight Therapeutics Inc. (TSE:GUD) Insider Purchases 6,200 Shares of Stockmarketbeat.com - April 8 at 11:48 AMKnight Therapeutics Inc. (TSE:GUD) Insider Sime Armoyan Acquires 351,000 Sharesinsidertrades.com - March 26 at 4:18 AMKnight Therapeutics Inc. (TSE:GUD) Insider Sime Armoyan Buys 351,000 Sharesmarketbeat.com - March 25 at 6:22 PMEarnings call: Knight Therapeutics announced record revenues of $343 millioninvesting.com - March 23 at 3:55 PMRoyal Bank of Canada Raises Knight Therapeutics (TSE:GUD) Price Target to C$7.00marketbeat.com - March 22 at 2:31 PMKnight Therapeutics Full Year 2023 Earnings: Misses Expectationsfinance.yahoo.com - March 22 at 7:22 AMKnight Therapeutics Inc (04K.SG)ca.finance.yahoo.com - March 20 at 7:00 PMStocks in play: Knight Therapeutics Inc.ca.finance.yahoo.com - March 14 at 12:54 PMRaymond James Research Analysts Increase Earnings Estimates for Knight Therapeutics Inc. (TSE:GUD)marketbeat.com - March 8 at 7:22 AMFavourable Signals For Knight Therapeutics: Numerous Insiders Acquired Stockfinance.yahoo.com - March 7 at 8:15 AMAnalysts Offer Predictions for Knight Therapeutics Inc.'s Q4 2023 Earnings (TSE:GUD)marketbeat.com - March 1 at 6:36 AMStocks in play: Knight Therapeutics Inc.,ca.finance.yahoo.com - February 29 at 2:45 PMKnight Therapeutics launches Minjuvi in Brazilmsn.com - February 29 at 9:44 AMBrokers Issue Forecasts for Knight Therapeutics Inc.'s FY2023 Earnings (TSE:GUD)marketbeat.com - February 29 at 7:39 AMKnight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazilfinance.yahoo.com - February 21 at 8:54 PMInsider Selling: Knight Therapeutics Inc. (TSE:GUD) Insider Sells 28,200 Shares of Stockmarketbeat.com - January 23 at 1:54 PMKnight Therapeutics Inc. (TSE:GUD) Insider Sime Armoyan Sells 91,000 Sharesmarketbeat.com - January 22 at 2:42 PMKnight Therapeutics Announces Product Launch for IMVEXXY® in Canadafinance.yahoo.com - January 4 at 8:34 AMKnight Therapeutics Enters into Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree® (viloxazine) in Canadafinance.yahoo.com - December 19 at 7:42 AMKnight Therapeutics Inc. places No. 90 on The Globe and Mail's fifth-annual ranking of Canada's Top Growing Companiesfinance.yahoo.com - October 2 at 5:46 PMClosing Bell: Knight Therapeutics Inc flat on Thursday (GUD)theglobeandmail.com - September 14 at 5:50 PMKnight Therapeutics (KHTRF) Receives a Buy from RBC Capitalmarkets.businessinsider.com - August 12 at 11:28 PMTrading For This Specialty Pharma Company is up Following Second Quarter Resultstheglobeandmail.com - August 10 at 12:47 PMKnight Therapeutics Reports Second Quarter 2023 Resultsfinance.yahoo.com - August 10 at 7:46 AMNotice of Knight Therapeutics' Second Quarter 2023 Results Conference Callfinance.yahoo.com - August 3 at 8:40 PMClosing Bell: Knight Therapeutics Inc up on Tuesday (GUD)theglobeandmail.com - June 7 at 1:52 AMKnight to Present at the Jefferies 2023 Healthcare Conference in New York Cityfinance.yahoo.com - June 2 at 8:29 AMClosing Bell: Knight Therapeutics Inc down on Wednesday (GUD)theglobeandmail.com - May 31 at 9:25 PMSamira Sakhia Bought 12% More Shares In Knight Therapeuticsfinance.yahoo.com - May 26 at 8:59 AMSamira Sakhia Bought 12% More Shares In Knight Therapeutics \finance.yahoo.com - May 26 at 8:59 AMShareholders in Knight Therapeutics (TSE:GUD) are in the red if they invested five years agofinance.yahoo.com - May 23 at 9:41 AMClosing Bell: Knight Therapeutics Inc down on Monday (GUD)theglobeandmail.com - May 8 at 7:14 PMNotice of Knight Therapeutics' First Quarter 2023 Results Conference Callfinance.yahoo.com - May 4 at 7:37 AMClosing Bell: Knight Therapeutics Inc down on Friday (GUD)theglobeandmail.com - April 28 at 6:49 PMKnight to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conferencefinance.yahoo.com - April 18 at 8:31 AMClosing Bell: Knight Therapeutics Inc up on Monday (GUD)theglobeandmail.com - April 10 at 7:05 PMKnight Therapeutics Inc. ranks on The Globe and Mail's fourth-annual Women Lead Here benchmark of executive gender diversitymarketwatch.com - March 25 at 7:52 AMKnight Therapeutics (TSE:GUD) Given New C$6.00 Price Target at National Banksharesmarketbeat.com - March 24 at 2:24 PMKnight Therapeutics Reports Fourth Quarter and Year-End 2022 Resultsfinance.yahoo.com - March 23 at 8:05 AMKnight Therapeutics Stock (OTC:KHTRF), Quotes and News Summarybenzinga.com - February 28 at 6:49 PM Get Knight Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GUD and its competitors with MarketBeat's FREE daily newsletter. Email Address Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. GUD Media Mentions By Week GUD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GUD News Sentiment▼0.530.36▲Average Medical News Sentiment GUD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GUD Articles This Week▼40▲GUD Articles Average Week Get Knight Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GUD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACB News OGI News CPH News CRDL News HLS News CRON News WEED News EXE News VMD News CARE News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:GUD) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithCould Your Accounts Be Frozen?Allegiance GoldDollar CancelledLear CapitalRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
